- TV Footage
- Integrated Annual Reports
- Quarterly Reports
- Bayer Magazine
- BEENOW Magazine
- Farming’s Future Magazine
- research Magazine
- technology solutions Magazine
- From Molecules to Medicine
- From Molecules to Veterinary Medicines Brochure
- Integrated Weed Management
- Names | Figures | Facts
- Transfers of Value to Physicians Brochure
- Newsletter Overview
- Social Media
- Media Contact
Leverkusen, February 16, 2018 – The Bayer people who volunteer time and effort to support community projects really are role models. After all, their volunteering is making a difference to people, society and the environment in numerous countries around the world. In 2017, Bayer Cares Foundation received 330 applications from 58 countries and the 113 winners chosen will be receiving EUR 402,151 to support their projects. This is the highest annual sum awarded since Bayer Cares Foundation began supporting volunteering work in 2007. Since then the Role Model Program has had a powerful societal impact, with more than EUR 2.6 million spent to support 745 projects in over 70 countries.
20 projects in Eastern Europe
Bayer Cares Foundation awarded a total of EUR 94,962 to 20 community projects from seven countries of Eastern Europe: the Russian Federation, the Czech Republic, Kazakhstan, the Republic of Moldavia, Romania, Turkey and the Ukraine. One of the winning projects from the Russian Federation was “Dolphin and Wonder”, where a colleague from Bayer’s Kazan is involved in running dolphin therapy sessions for children with severe mental disorders and their families. Another project known as “Dobrodusha” (KindSoul) is all about implementing new technologies for the socio-psychological rehabilitation and education of orphans and children in difficulty.
“In these award-winning projects we are mainly supporting employees whose engagement and innovative ideas are helping to solve social challenges,” says Dr. Hartmut Klusik, the Bayer Board of Management member responsible for HR and sustainability who also chairs the Bayer Cares Foundation Executive Committee. “Through their projects they are bringing new impulses for better living conditions and acting as important ambassadors in conveying our leitmotif as a responsible innovation company.”
The worldwide impact of Bayer’s Role Model Program is documented by the broad geographical spread of the award-winning projects. Besides the seven Eastern Europe countries listed above, projects in the following countries were given financial support:
• Western Europe: France, Germany, Ireland, Italy, Sweden and Switzerland
• North and South America: Argentina, Brazil, Canada, Chile, Colombia, Cuba, Ecuador, Guatemala, Honduras, Mexico, Nicaragua, Peru, USA and Venzuela
• Middle East: Israel and Jordan
• Africa: Cote d’Ivoire, Kenya, Morocco and South Africa
• Asia: China, India, Malaysia, Pakistan, Singapore, South Korea, Thailand and Vietnam
• Oceania: New Zealand
Bayer Cares Foundation
As the social welfare foundation of the innovation company Bayer, the Bayer Cares Foundation sees itself in particular as an initiator, promoter and partner for innovation at the interface between industry and the social sector. The sponsorship programs are focused on people – their commitment to public welfare, their wealth of ideas in fulfilling social needs, and those that arise in times of emergency. The foundation’s funding activities are a central element of Bayer’s global social commitment of around €50 million annually – with the focus on promoting scientific education and leading-edge research, as well as on providing health care and nutrition and meeting the basic social needs of people who live near the company’s sites. You can find out more about the Bayer Cares Foundation at: www.bayer-foundations.com
Note to editorial staff:
A detailed list of funding opportunities can be found in the appendix.
Find more information at www.bayer.com.
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.